Yahoo Sport 
Gleison Tibau Ditches USADA Appeal, Admits to EPO Use
Lightweight Gleison Tibau tested positive to Erythropoietin (EPO) during out-of-competition and in-competition drug tests surrounding UFC Fight Night 77 in November. He defeated Abel Trujillo by first-round submission at the event in Sao Paulo, Brazil.
On Wednesday, Tibau announced that he would no longer appeal the United States Anti-Doping Agency (USADA) findings and accept the minimum two-year suspension. MMAJunkie first reported the news.
HOT TOPIC > BJ Penn Accused of Sexual Assault, UFC Puts His Return on Hold
“They asked me if I wanted to appeal, but it was too tiresome. Three months of meetings at the court, that’s tiring. I don’t want to appeal anymore. I’m done,” Tibau told MMAFighting.com.
“If I wanted to continue the appeal, I would have to pay all the court costs from now on, I would have to pay my lawyer, and the suspension would probably go down only three or six months. I don’t know, so I decided not to appeal,” said the 32-year-old Brazilian.
Tibau admitted to using EPO, but said it was done by mistake.
“I have to apologize to my fans because it was a medical mistake. We used a substance we thought wouldn’t be anything, we used it out of competition. I have my conscience clear that I took it without imagining I was doing something wrong. It’s going to be hard for me, but I will pay the price for my mistake,” he said.
As of the time of publication, Tibau’s UFC Fight Night 77 win over Trujillo stands.
